Literature DB >> 16641963

Flu-vaccine makers toil to boost supply.

Carina Dennis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16641963     DOI： 10.1038/4401099a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Enhanced growth of seed viruses for H5N1 influenza vaccines.

Authors:  Taisuke Horimoto; Shin Murakami; Yukiko Muramoto; Shinya Yamada; Ken Fujii; Maki Kiso; Kiyoko Iwatsuki-Horimoto; Yoichiro Kino; Yoshihiro Kawaoka
Journal:  Virology       Date:  2007-07-24       Impact factor: 3.616

2.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

3.  Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.

Authors:  Wendy A Keitel; Cornelia L Dekker; ChrisAnna Mink; James D Campbell; Kathryn M Edwards; Shital M Patel; Dora Y Ho; Helen K Talbot; Kuo Guo; Diana L Noah; Heather Hill
Journal:  Vaccine       Date:  2009-03-25       Impact factor: 3.641

4.  A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development.

Authors:  Zoltan Vajo; John Wood; Lajos Kosa; Istvan Szilvasy; Gyorgy Paragh; Zsuzsanna Pauliny; Kálmán Bartha; Ildiko Visontay; Agnes Kis; Istvan Jankovics
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

5.  Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells.

Authors:  Shin Murakami; Taisuke Horimoto; Le Quynh Mai; Chairul A Nidom; Hualan Chen; Yukiko Muramoto; Shinya Yamada; Ayaka Iwasa; Kiyoko Iwatsuki-Horimoto; Masayuki Shimojima; Akira Iwata; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

6.  Inactivated whole virus influenza A (H5N1) vaccine.

Authors:  Zoltan Vajo; Lajos Kosa; Ildiko Visontay; Mate Jankovics; Istvan Jankovics
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

7.  Yearly licensing studies from 1997 to 2007 of the inactivated whole virus seasonal influenza vaccine fluval--a useful approach to pandemic vaccine development even in less well developed countries?

Authors:  Zoltan Vajo; Lajos Kosa; Istvan Szilvasy; Zsuzsanna Pauliny; Kálmán Bartha; Ildiko Visontay; Mate Jankovics; Agnes Kis; Istvan Jankovics
Journal:  Influenza Other Respir Viruses       Date:  2008-11       Impact factor: 4.380
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.